title: Prostate cancer and life insurance.
abstract: Prostate cancer is comprehensively reviewed from the perspective of risk-stratification. Epidemiology and staging are assessed. The diagnostic implications are described. Treatment strategies are outlined and underwriting implications are presented.
authors.affiliation: New England Financial, 501 Boylston Street, Boston, MA 02116-3706, USA.
authors.forename: A E
authors.initials: AE
authors.lastname: Milano
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D014408:Biomarkers, Tumor; D005006:Ethnicity / Q000706:statistics & numerical data; D006801:Humans; D015994:Incidence; D007352:Insurance, Life; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D012306:Risk
chemical_list: D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen